Crossref
A Review of the Treatment Options in Recurrent Glioblastoma: Focus on Bevacizumab
Clinical Medicine Reviews in Oncology · 2011
DOI: 10.4137/cmro.s1528 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine Reviews in Oncology, 2011. Verfasst von Raymund L. Yong and John K. Park. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Park, R. L. Y. A. J. K. (2011). A Review of the Treatment Options in Recurrent Glioblastoma: Focus on Bevacizumab. Clinical Medicine Reviews in Oncology. https://doi.org/10.4137/cmro.s1528
Vancouver
Park RLYAJK. A Review of the Treatment Options in Recurrent Glioblastoma: Focus on Bevacizumab. Clinical Medicine Reviews in Oncology. 2011. doi:10.4137/cmro.s1528
BibTeX
@article{Park2011,
author = {Park, Raymund L. Yong and John K.},
title = {A Review of the Treatment Options in Recurrent Glioblastoma: Focus on Bevacizumab},
journal = {Clinical Medicine Reviews in Oncology},
year = {2011},
doi = {10.4137/cmro.s1528}
}
EUVIMED